Interestingly, both increased cysteine protease inhibition and cystatin A expression were associated with better survival in NSCLC [25], and enforced expression of CSTA reduced metastasis in breast cancer [26]. The gene discussed is CSTA; the disease is non-small cell lung carcinoma.